Christophe Caux

The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers

NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes

IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population

ZEB1 transcription factor promotes immune escape in melanoma

Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer

<scp>HERVs</scp> characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy

Gene signature of circulating platelet‐bound neutrophils is associated with poor prognosis in cancer patients

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors

Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 ⁺ and CD8 ⁺ T‐cell protective responses to breast cancer

Durable and controlled depletion of neutrophils in mice

IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer

CD163⁺ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC

Repurposing infectious disease vaccines for intratumoral immunotherapy

Cold Tumors: A Therapeutic Challenge for Immunotherapy

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Neutrophil Heterogeneity in Cancer: From Biology to Therapies

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade

MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).